Zealand Pharma's market cap is currently $5.22B. The company's EPS TTM is $16.591542219999997; its P/E ratio is 4.95; Zealand Pharma is scheduled to report earnings on August 14, 2025, and the estimated EPS forecast is $-1.24. See an overview of income statement, balance sheet, and cash flow financials.
